| |
|
|
|
Arcadia Biosciences Inc.  
|
|
6.96 1.41 (0.25%) |
08-21 16:00 |
|
Open: |
5.58 |
Pre close: |
5.55 |
Target:
|
10.69
|
|
High: |
7.22 |
Low: |
5.58 |
Resistance:
|
9.15
10.69
|
|
Volume: |
3,254,301 |
Market Cap: |
44M |
Support:
|
4.62
1.82
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
6.68
 |
MACD |
MACD(12,26):
|
0.99  |
|
MA(20): |
4.12 |
Signal(12,26,9): |
0.65 |
|
MA(100): |
4.69 |
Stochastic Oscillator |
%K(14,3):
|
59.75 |
|
MA(250): |
4.78 |
%D(3): |
62.71 |
|
Average Volume(K) |
3-Month: |
253684
|
52-Week |
High:
|
10.40 |
|
10-Days: |
1445408 |
Low: |
1.82 |
|
RSI |
RSI(14):
|
64.27 |
Change(%): |
11.7 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.940 |
Return on Equity (ttm) |
-55.7 |
Shares Out. (M) |
4.78 |
|
EPS Est. Current Year |
-0.360 |
Return on Assets (ttm) |
-39.1 |
Shares Float (M) |
4.68 |
|
EPS Est. Next Year |
-0.220 |
PEG Ratio |
-0.14 |
% Held by Insiders |
33.31 |
|
EPS Est. Next Quarter |
-0.080 |
Qtrly Rev. Growth |
-53.4 |
% Held by Institutions |
5.92 |
|
Forward EPS |
1.#IO |
Gross Profit (p.s.) |
-1.103 |
Shares Short (K) |
56 |
|
Book Value (p.s.) |
1.320 |
EBITDA (p.s.) |
-3.665 |
P/E |
-7.40 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
5.27 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-15.14 |
P/S |
138620000.00 |
|
Operating Margin |
-1502.38 |
Levered Free Cash Flow
(M) |
-9.45 |
P/CF |
-2.20 |
|
|
|
|
|
|
